El estudio muestra una tasa de control de la enfermedad del 67% y apunta que los anticuerpos de Sym004 consiguen una penetración superior y, por tanto, mejores resultados que el cetuximab o el panitu...
Read moreThe door to optimize the standard chemotherapy treatment has been opened: “if we combine the chemotherapy of cytotoxic agents (like cisplatin) with selective inhibitors of these kinases, that don’...
Read moreLos resultados evidencian que la desregulación del metabolismo es una característica del cáncer de mama triple negativo y permite diseñar nuevas estrategias terapéuticas en este agresivo subtipo ...
Read moreThe study, published in the journal ‘EMBO Molecular Medicine’, shows for the first time that telomeres may be a therapeutic target for cancer treatment
Read moreLos investigadores subrayan el alto alcance de la inmunotoxina, al abarcar la mayor parte de los casos de cáncer colorrectal. “De acuerdo con estudios anteriores, el marcador tumoral GPA33, diana d...
Read moreThe combination of TTFields and chemotherapy did demonstrate a delay in tumour growth compared to the animals treated only with chemotherapy (47% average relative reduction of tumour growth)
Read moreThe study sets the scene for the development of a test that measures between four and six gene in the tissue around the tumour and that could allow the identification of those patients at risk of rela...
Read moreThe results of this trial, although modest in terms of benefit, are important since they offer these patients an alternative therapy against the advancement of their disease – whereas previously no ...
Read moreThis project aims to develop useful bioinformatics tools and applications, and autonomously usable for analysing the huge amount of data and knowledge generated in healthcare and biomedical research i...
Read moreGracias a esta estrategia, el 95% de los pacientes candidatos a trasplante alogénico disponen potencialmente de un donante apropiado entre sus familiares de primer grado
Read moreEsta mutación se trasmite con una herencia recesiva, de tal modo que aquellos individuos que presentan la mutación en homocigosis, los dos alelos mutados, tienen un riesgo muy alto de desarrollar c ...
Read moreResearch led by the Vall d'Hebron Institute of Oncology´s Growth Factors Group headed by Joaquín Arribas, shows the inhibition of certain pro-tumoral factors secreted by cells showing signs of prema...
Read more